Key result
Carotid endarterectomy cuts stroke or death risk ~41% compared to optimal medical therapy.
Why the study?
Contemporary optimal medical therapy has substantially improved outcomes in asymptomatic carotid artery stenosis, leaving the comparative effectiveness of OMT alone, carotid artery stenting, and carotid endarterectomy uncertain after recent randomized trials.
Does carotid endarterectomy or carotid artery stenting reduce the composite of periprocedural stroke or death or follow-up ipsilateral ischemic stroke compared with optimal medical therapy alone in patients with asymptomatic carotid artery stenosis?
Meta-Analysis (n=9,257)
Does carotid endarterectomy or carotid artery stenting reduce the composite of periprocedural stroke or death or follow-up ipsilateral ischemic stroke compared with optimal medical therapy alone in patients with asymptomatic carotid artery stenosis?
In contemporary RCTs of asymptomatic carotid stenosis, carotid endarterectomy lowers the risk of periprocedural stroke/death or long-term ipsilateral stroke compared to both optimal medical therapy alone and carotid artery stenting.
Answers are grounded in this paper and cite their sources.
Endarterectomy should be prioritized over stenting or medical therapy alone for asymptomatic stenosis; extends contemporary RCT network evidence.
Objectives: Contemporary optimal medical therapy (OMT) has substantially improved outcomes in patients with asymptomatic carotid artery stenosis. However, the comparative effectiveness of OMT alone, carotid artery stenting (CAS), and carotid endarterectomy (CEA) remains uncertain after recent randomized trials. Methods: MEDLINE, EMBASE, and CENTRAL were searched through January 2026 to identify studies reporting the long-term outcomes following CEA, CAS, or OMT. The primary outcome was a composite of any stroke or death during the periprocedural period or ipsilateral ischemic stroke during the remaining follow-up. The secondary outcomes included periprocedural death or stroke, and postprocedural ipsilateral stroke during follow-up. A random-effects network meta-analysis was conducted to compare the outcomes. Reconstructed time-to-event data from Kaplan-Meier curves were pooled, and landmark analyses were performed to assess time-varying treatment effects and delineate the net benefits of CAS or CEA compared with OMT. We excluded studies conducted earlier than 2000 to reflect contemporary practice. Results: Seven RCTs involving 9,257 patients (CAS, n = 4,307; CEA, n = 3,585; OMT, n = 1,365) were analyzed for the primary outcome, with a median follow-up of 45 months. Compared with OMT, CEA was associated with a lower risk of the primary outcome (hazard ratio [HR] 0.59; 95% CI 0.40-0.89), whereas CAS did not demonstrate a statistically significant difference (HR 0.78; 95% CI 0.52-1.16). CAS was associated with a higher risk of the primary endpoint compared with CEA (HR 1.31; 95% CI 1.03-1.67), largely driven by periprocedural death or stroke. Periprocedural events occurred in 1.97% (95% CI 1.41-2.73) of patients undergoing CEA and 2.62% (95% CI 1.95-3.51) of those undergoing CAS. In a landmark analysis beyond the periprocedural period, both CEA and CAS were effective in reducing stroke risk compared with OMT. Conclusion: Among patients with asymptomatic carotid stenosis, CEA was associated with a lower risk of a composite of perioperative stroke or death or ipsilateral stroke during follow-up than OMT alone or CAS. The net benefit of CAS compared to OMT depends on minimizing periprocedural events rate, underscoring the importance of patient selection and procedural expertise.
No takes yet. Share an insight, caveat, or question.
Yoshida et al. (2026) conducted a meta-analysis in Asymptomatic carotid artery stenosis (n=9,257). Carotid endarterectomy (CEA) or carotid artery stenting (CAS) vs. Optimal medical therapy (OMT) was evaluated on Composite of any stroke or death during the periprocedural period or ipsilateral ischemic stroke during the remaining follow-up (HR 0.59, 95% CI 0.40-0.89). Carotid endarterectomy reduced periprocedural stroke/death or follow-up ipsilateral stroke vs optimal medical therapy (HR 0.59; 95% CI 0.40-0.89) and carotid stenting (HR 1.31; 95% CI 1.03-1.67).
Synapse has enriched 10 related papers. Consider them for comparative context: